Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) EBT (2019 - 2026)

Profound Medical has reported EBT over the past 7 years, most recently at $35.2 million for Q4 2025.

  • For Q4 2025, EBT rose 779.29% year-over-year to $35.2 million; the TTM value through Dec 2025 reached $1.1 million, up 103.78%, while the annual FY2025 figure was $1.1 million, 103.78% up from the prior year.
  • EBT for Q4 2025 was $35.2 million at Profound Medical, up from -$7.9 million in the prior quarter.
  • Over five years, EBT peaked at $35.2 million in Q4 2025 and troughed at -$51.0 million in Q4 2021.
  • A 5-year average of -$5.7 million and a median of -$111000.0 in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: crashed 336.34% in 2021 and later soared 779.29% in 2025.
  • Year by year, EBT stood at -$51.0 million in 2021, then increased by 6.97% to -$47.4 million in 2022, then dropped by 1.2% to -$48.0 million in 2023, then soared by 89.2% to -$5.2 million in 2024, then skyrocketed by 779.29% to $35.2 million in 2025.
  • Business Quant data shows EBT for PROF at $35.2 million in Q4 2025, -$7.9 million in Q3 2025, and -$15.6 million in Q2 2025.